News Pfizer's Arena buyout looks canny, as etrasimod aces phase 3... Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of Arena Pharmaceu
News Flush with COVID cash, Pfizer tables $6.7bn bid for Arena Pfizer has found another use for the windfall profits it is making from it BioNTech-partnered COVID-19 vaccine, agreeing to buy Arena Pharma and its late-stage ulcerative colitis drug etras
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
